Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Who’s Going to Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
137 organizations and 120 speakers at Biomarkers Europe 2026, a ~1,000-person, evenly mixed biopharma & vendor meeting of biomarker, multi-omics and pathology leads. As of Oct 8, 2026.
Format
Topic
Top represented
Showing 1–8 of 137 organizations
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company with marketed medicines in oncology, immunology, neuroscience and cardiovascular disease. | Talk Tue Oct 13 9:15am–9:40am Precision Medicine Beyond the Hype: Delivering Real Clinical Impact Drug–diagnostic commercialization & access Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Talk Tue Oct 13 2:30pm–2:55pm Spatial Autoimmunity - Challenges and Opportunities in Salivary Glands Digital pathology & spatial biomarkers Talk Tue Oct 13 2:55pm–3:20pm Translational Biomarkers For Evaluating Biologic Drug Efficacy Biomarker discovery & translation Talk Tue Oct 13 3:20pm–3:45pm Leveraging UK Biobank to Derive Proteomic Signatures Representative of Disease Biology of Dermatological Indications Genomics, proteomics and multi-omics Talk Wed Oct 14 9:10am–9:35am Digital Health Technology Adoption In Clinical Development Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access Panel Wed Oct 14 1:00pm–1:30pm Biomarker Strategies In Neurodegenerative Therapeutics Biomarker discovery & translation Panel Wed Oct 14 3:15pm–4:05pm AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision Multimodal & AI-enabled precision medicine |
Labcorp Burlington, NC | ◆Diamond Sponsor |
Laboratory services company offering diagnostic testing, central lab and biomarker services for drug trials, and companion diagnostic development. | Talk Tue Oct 13 9:40am–10:05am Advancing Precision Oncology with Companion Diagnostics: Accelerating Development with elio™ Tissue Complete CDx Clinical & companion diagnostic developmentGenomics, proteomics and multi-omics Talk Tue Oct 13 3:20pm–3:45pm An Open Approach To Biomarker Discovery And Companion Diagnostics Biomarker discovery & translationClinical & companion diagnostic development Workshop Wed Oct 14 11:20am–1:20pm Enabling Global Precision Oncology Through Integrated Testing, Monitoring, and Companion Diagnostic Strategies Clinical & companion diagnostic development Talk Wed Oct 14 2:50pm–3:15pm From Biomarkers To Biological Signatures: Enabling Precision Prevention And Clinical Trials In Cardiometabolic Disease Biomarker discovery & translation |
AstraZeneca Cambridge, UK | |
Global pharmaceutical company developing and marketing medicines in oncology, cardiovascular, renal, respiratory and rare diseases. | Talk Tue Oct 13 9:15am–9:40am From Digital Pathology To Precision Medicine: Scaling AI-Driven Image Analysis Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Panel Tue Oct 13 12:40pm–1:30pm Overcoming Challenges In Deploying Foundation Models, LLMs And Agentic AI For Pathology Workflows Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Panel Tue Oct 13 5:10pm–6:00pm AI-Powered Precision Medicine Multimodal & AI-enabled precision medicine Panel Wed Oct 14 8:05am–8:30am Bringing Digital & AI Into The Clinic: How To Globalise Computational Pathology Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Wed Oct 14 11:45am–12:10pm Digital Biomarkers, Cancer Networks And Clinical Action Multimodal & AI-enabled precision medicine Panel Wed Oct 14 1:00pm–1:30pm Deploying Computational Pathology Across The Pharma Pipeline Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Merck Healthcare Darmstadt, Germany | |
Healthcare business of Merck KGaA, Darmstadt, developing and marketing medicines in oncology, neurology, immunology and fertility. | Talk Tue Oct 13 11:50am–12:15pm Precision Medicine: Drug/CDx Regulatory Strategy In The US And EU Clinical & companion diagnostic development Panel Tue Oct 13 12:40pm–1:30pm IVDR Regulations & Their Impact Clinical & companion diagnostic development Talk Tue Oct 13 2:30pm–2:55pm Profiling Tumor-Associated Antigens - A Screening Approach Using Spatial Highplex IF Digital pathology & spatial biomarkers Talk Tue Oct 13 2:55pm–3:20pm To Multiplex Or Not To Multiplex- The Question In Preclinical Drug Development Biomarker discovery & translation Talk Wed Oct 14 8:40am–9:10am From Data To Design: AI-Driven Generative Biology And The Future Of Personalized Medicine Multimodal & AI-enabled precision medicine Panel Wed Oct 14 3:15pm–4:05pm AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision Multimodal & AI-enabled precision medicine |
Roche Basel, Switzerland | |
Swiss healthcare group whose pharmaceuticals division develops medicines in oncology, neuroscience, immunology and other areas. | Talk Tue Oct 13 11:50am–12:15pm Computational Co-Intelligence - Closing The Gap Between Technology And Patients' Needs Multimodal & AI-enabled precision medicine Talk Tue Oct 13 12:15pm–12:40pm From Spatial Biology To Therapeutic Insight: Lessons From Alzheimer’s Disease And Oncology Digital pathology & spatial biomarkers Panel Tue Oct 13 12:40pm–1:30pm Overcoming Challenges In Deploying Foundation Models, LLMs And Agentic AI For Pathology Workflows Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Panel Tue Oct 13 5:10pm–6:00pm AI-Powered Precision Medicine Multimodal & AI-enabled precision medicine Talk Wed Oct 14 11:45am–12:10pm Stain Transfer for Pathology: Learning Cross Stain Representations from H&E Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Deciphex Dublin, Ireland | ◆Platinum Sponsor |
Provides pathology services and digital pathology software for drug development, combining a global pathologist network, image management and AI. | Talk Tue Oct 13 2:30pm–2:55pm Building The Future of Pathology AI: Foundation Models For Clinical Trials And CDx Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Talk Tue Oct 13 4:50pm–5:00pm AI & Data Zone Presentation: Mining Archival Biopsies for Progression Biomarkers in MASLD Using Cipher-X Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Talk Wed Oct 14 9:35am–10:00am Scaling Expert Pathology: Global Networks Meet Bespoke AI For Pharma Partners Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Panel Wed Oct 14 1:00pm–1:30pm Deploying Computational Pathology Across The Pharma Pipeline Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Lundbeck Copenhagen, Denmark | |
Danish pharmaceutical company focused on brain diseases, with medicines in psychiatry, neurology and migraine. | Talk Tue Oct 13 8:45am–9:15am New Frontiers In Precision Medicine – The Neurology Example Biomarker discovery & translation Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation Panel Wed Oct 14 1:00pm–1:30pm Biomarker Strategies In Neurodegenerative Therapeutics Biomarker discovery & translation Talk Wed Oct 14 4:05pm–4:30pm Using Biomarkers To Drive Decision-Making In Neurodegenerative Diseases Biomarker discovery & translation |
UMC Utrecht Utrecht, Netherlands | |
University medical center in Utrecht combining patient care, research and teaching. | Talk Tue Oct 13 12:15pm–12:40pm AI Supported Histopathology - Implementation & Validation Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Tue Oct 13 5:35pm–6:00pm Decoding Tumor Histology With AI To Personalize Cancer Treatment Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Panel Tue Oct 13 6:00pm–6:25pm Designing Prognostic & Predictive Biomarkers With Pathology: Implementation of AI in Diagnostics Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Instantly find 20 buyers from companies at Biomarkers Europe 2026
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
When and where was Biomarkers Europe 2026?
Biomarkers, CDx & Precision Medicine 2026 (with NextGen Omics, Tech & Data Europe) ran October 13–14, 2026, at the Congress Centre Basel in Basel, Switzerland.
What conference is this?
Biomarkers, CDx & Precision Medicine is a European biomarker meeting, held October 13–14, 2026 at the Congress Centre Basel alongside the NextGen Omics and Tech & Data meetings. It brings together biomarker, translational, diagnostics, multi-omics and pathology leads from pharma, biotech, academia and healthcare with the diagnostics, omics and data companies that serve them.
What is in this guide?
Every organization we can place at Biomarkers Europe 2026: 120 speakers from the public agenda (108 talks, panels, roundtables and sponsored presentations) rolled up to their companies and institutions, and the 75 sponsors of the co-located meetings with their level — 137 organizations in one list. Speakers appear as job titles, never by name. The organizers publish no attendee list and no booth numbers.
How are organizations typed?
By the role an organization plays in precision medicine: drug developers (large pharma and biotech), diagnostics companies and testing labs, then instrument and reagent companies, software, data and AI companies, CROs and central labs, and consultancies and other services — and academic, government and non-profit bodies. The topic filters are judged from each session’s title.
How current is it?
Pulled from the public agenda, speaker list and sponsor list on October 8, 2026, five days before the meeting.
Browse Biomarkers Europe 2026 by
Organization type
Topic
Everyone
Organizations with their own page
101 organizations — every exhibitor and every organization with 2 or more presentations.
- 10x Genomics
- AbbVie
- Agilent
- Almac
- arcoris bio
- Ardena
- Aspect Analytics
- AstraZeneca
- Avenna
- Barco
- Barts Cancer Institute, Queen Mary University of London
- BD
- Bio-Techne Spatial
- BioAge Labs
- BioAgilytix
- BioLizard
- Boston Limited
- Brunel University of London
- Cancer Research UK
- Cavidi
- CellCarta
- Cerba Research
- Codetta Bio
- Crown Bioscience
- cytario
- Cytosurge
- Data Intuitive
- Deciphex
- Diagenode
- DoMore Diagnostics
- Endogene
- ERBC
- European Institute of Oncology (IEO)
- Flanders Investment & Trade
- Foundation Medicine
- Glencoe Software
- GSK
- Hamamatsu
- HealthSeed
- Histomography
- ICON
- Illumina
- Indica Labs
- Ingenix
- Institute for Molecular Medicine Finland (FIMM)
- IQVIA Laboratories
- Labcorp
- Labena
- Leica Microsystems
- Logical Biological
- Luminex
- Lundbeck
- MedInsights
- Merck Healthcare
- Merck Life Science
- Meso Scale Discovery
- Metabolon
- Meteor Biotech
- Methylomics
- MetwareBio
- Miltenyi Biotec
- Mission Bio
- Moleculent
- Monte Rosa Therapeutics
- n6
- Navinci
- Novartis
- Nygen
- OHMX.bio
- One Biosciences
- OracleBio
- Pathcore
- Precision for Medicine
- Precursion
- Proscia
- Proteome Sciences
- Quanterix
- Randox Biosciences
- RareCyte
- Revolune
- Roche
- Roche Diagnostics
- Royal Brompton & Harefield Hospitals
- Sanofi
- Seer
- Single Cell Discoveries
- Singular Genomics
- Spear Bio
- Step Pharma
- StratifAI
- Synexa Life Sciences
- Twist Bioscience
- UCB
- UltraBright Biotech
- UMC Utrecht
- University of Exeter
- Uppsala University
- Velindre University NHS Trust
- Vizgen
- Watchmaker Genomics
- ZEISS Microscopy
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction